Hulin, C., Offner, F., Moreau, P., Roussel, M., Belhadj, K., Benboubker, L., Caillot, D., Facon, T., Garderet, L., Kuhnowski, F., Stoppa, A.-M., Kolb, B., Tiab, M., Jie, K.-S., Westerman, M., Lambert, J., Pei, L., Vanquickelberghe, V., de Boer, C., Vermeulen, J., Kampfenkel, T., Sonneveld, P. and van de Donk, N. W. (2021) “Stem cell yield and transplantation in transplant-eligible newly diagnosed multiple myeloma patients receiving daratumumab + bortezomib/thalidomide/dexamethasone in the phase 3 CASSIOPEIA study”, Haematologica. Pavia, Italy, 106(8), pp. 2257-2260. doi: 10.3324/haematol.2020.261842.